Mutual Funds Commodities Research Tax Planning IPO Our Team Contact Us  
Google
Web www.equitybulls.com
Stock Report

| More

AstraZeneca signs MoU with Indian Diabetes Research Society (RSSDI) to empower 1 Crore Indian Diabetic patients by 2023

Posted On: 2020-11-27 10:21:15 (Time Zone: Arizona, USA)


AstraZeneca India (AstraZeneca Pharma India Limited), a leading science-led biopharmaceutical company, today signed a memorandum of understanding with the Research Society for Study of Diabetes in India (RSSDI). This MOU is aimed at digitising and driving correct awareness of Diabetes amongst people to prevent complications arising from the uncontrolled incidence of the disease.

RSSDI is the largest organisation of Diabetes health care professionals and researchers in Asia with around 6000 members from amongst physicians, diabetologists, endocrinologists, as well as paramedical personnel. The organisation has been instrumental in extensive research on Diabetes, as well as continuing diabetes education initiatives in India. As a key facet of this dual association, AstraZeneca unveiled a campaign-'Beyond Sugar', a three-year patient awareness program developed to benefit over 1 Crore people living with Diabetes across the country. This initiative will empower patients/caregivers to have conversations around Diabetes and make informed decisions about the management of the disease.

The International Diabetes Foundation Atlas on Diabetes shows that 1 in 11 people in south Asia have Diabetes and that India will have around 11.5 Crore diabetes patients by 2030. While 10% to 15% of the general population have Diabetes, a recent study suggested that 44% of patients hospitalised for Heart Failure (HF) have type 2 diabetes showcasing the steep correlation between Diabetes and HF. HF is a major health problem in India with post-admission mortality of 20%-30%. Chronic kidney diseases is associated with significant patient death and an increased risk of heart failure. Therefore, it is critical that Diabetes be controlled to decrease the incidence of HF and CKD in India.

Dr. Anil Kukreja, Vice President - Medical Affairs & Regulatory, AstraZeneca India, said "AstraZeneca has always been at the forefront of enabling patient-centric solutions for the management of non-communicable diseases. Despite currently available therapies, the awareness levels among the public is relatively low, resulting in uncontrolled Diabetes and additional complications of the heart and kidneys. The partnership between AstraZeneca and RSSDI will go a long way in supporting patient-centric digital awareness campaign and programs to raise awareness about Diabetes and its complications so that they can act early to manage or even prevent the complications".

Dr. Banshi Saboo, President - RSSDI and Organising Chairman 2020, said, "This partnership between RSSDI and AstraZeneca will result in increased awareness levels about Diabetes and its complications. Our vision is to touch 1 Crore lives in India over the next three years through this Digital patient-centric approach. In the COVID era, this digitally-powered initiative will also empower patients/caregivers to have better conversations with their doctors about the disease and make informed decisions in the management of Diabetes. All this will culminate towards shifting from the glucose centric management approach towards a holistic and an early Cardio-Renal focused management of type 2 diabetes."

Dr. Sanjay Agarwal, Secretary- RSSDI 2020, said, "Being the largest organisation of Diabetes doctors and researchers in Asia, RSSDI is always focused at elevating the patient outcomes in Diabetes with constant research and innovative solutions. Beyond Sugar is one such patient-centric initiative which will play a vital role along with our RSSDI state chapters to raise the awareness by leveraging social media and digital platforms. With the support of AstraZeneca, we aim to reach out to the patients, community and HCP to increase awareness about Diabetes and help patients initiate conversations about the prevention of complications in Diabetes."

Shares of ASTRAZENECA PHARMA INDIA LTD. was last trading in BSE at Rs.4538.5 as compared to the previous close of Rs. 4506.75. The total number of shares traded during the day was 9656 in over 2165 trades.

The stock hit an intraday high of Rs. 4579.75 and intraday low of 4396.6. The net turnover during the day was Rs. 43330373.


Source: Equity Bulls

Click here to send ur comments or to feedback@equitybulls.com





Other Headlines:

Sayaji Hotels Management Ltd enters into management agreement for 7 properties

GRSE Lays Keel of 3rd Ship of Prestigious Project 17A Advanced Stealth Frigate

NMDC revises prices of iron ore w.e.f. 06-03-2021

Aarti Speciality Chemicals Limited receives an approval accorded under PLI Scheme for Pharmaceutical Sector

Mawana Sugars Limited approves investment of Rs. 10 crores in Siel Industrial Estate Ltd

TVS Motor Company to provide free COVID-19 vaccination to all employees and their immediate family members

Satyam Silk Mills Ltd board to consider rights issue on March 10, 2021

GRM Overseas Ltd board to consider interim dividend on March 10, 2021

Rushil Decor Limited starts commercial production of MDF board at new Vizag plant

IIFL Securities Ltd board to consider interim dividend on March 10, 2021

DCW Limited allots debentures to Kotak Special Situations Fund

M G George Muthoot, Chairman of Muthoot Finance Limited passes away

Acuite Ratings & Research Limited update on rating of Edelweiss Financial Services Limited

Kotak Mahindra Bank Appoints Dr Ashok Gulati as an Additional Independent Director on its Board

Xanadu Realty ties up with Poddar Housing Development Limited in a mega portfolio deal

Edelweiss Financial Services Limited updates on credit rating of proposed NCD issue

IndiGrid signs the largest power transmission deal with Sterlite Power AUM to leapfrog to over INR 200 Bn

Indian Bank to divest stake in JV, ASREC India Ltd

Dai-ichi Karkaria Limited updates on Kasarwadi Land Deal

AKI India Ltd approves construction of effluent treatment plant

Kotak Silk Launches Eduseries for Financial Independence of Women

Ind-Ra has assigned ratings to JSW Hydro Energy Ltd

Shriram EPC Limited board to consider issue of preference shares to lenders

Suncare Traders Limited to demerge investment division to Madhav Infra Projects Ltd

Astral Poly Technik Limited fixes March 19, 2021 as record date for bonus issue

Mazagon Dock Shipbuilders Limited gifts refrigerated truck

Sandhar Technologies Ltd announces incorporation of step down subsidiary

NMDC LTD. board to consider interim dividend on Mar 11, 2021

CRISIL revises outlook of Canara Bank's long-term debt instruments

Hero MotoCorp launches 4-day special service and exchange carnival

ICICI Lombard General Insurance Company Limited board approves interim dividend of Rs. 4

Sun Pharma arm to acquire stake in WRS Bioproducts Pty Ltd, Australia

Kirloskar Oil Engines Ltd declares interim dividend of Rs. 1.50 for FY21

Glenmark signs on Rohit Sharma as brand ambassador of Candid Powder

Waa Solar Ltd Board aprovies 1:1 Bonus Issue

Coal India Ltd board approves 2nd interim dividend of Rs. 5

WeP Solutions Limited fixes March 12, 2021 as record date for rights issue

HGS Digital Partners with Automation Anywhere to Deliver End-to-End Process Automation Solutions in the Customer Experience Industry

PNB Housing Finance and YES BANK enter into strategic co-lending partnership

PVR Cinemas unveil Mysuru's Biggest 6-Screen multiplex in Forum Centre City Mall

Shilpa Medicare Ltd receives US FDA tentative approval for Apremilast Tablets, 10 Mg, 20 Mg, And 30 Mg

RITES Ltd Board to consider Second Interim Dividend on Mar 12, 2021

Mexico's GigNet selects Tejas Networks for its Metro Optical network in Cancun

Dilip Buildcon Ltd receives LOA from NHAI for 2 projects under Bangalore Chennai Expressway

BCPL Railway Infra secures path-breaking order in the railway electrification segment

Indian Bank to consider raising funds of Rs. 4000 crore through equity

Economic Times awards The Byke Hospitality Ltd. for Affordable Luxury Resort Stay

IndiGo strengthens regional connectivity, announces Bareilly as its 67th destination

TATA Tea Gold celebrates this Women's day by launching 'Dil Ki Suno' stories of today's women

Dabur launches 'Vatika Select' premium range of shampoos



Website Created & Maintained by : Chennai Scripts
West Mambalam, Chennai - 600 033,
Tamil Nadu, India

disclaimer copyright © 2005 - 2020